Vojjala, N.; Peshin, S.; Kattamuri, L.P.V.; Iqbal, R.; Dharia, A.; Jayakumar, J.; Iftekhar, R.; Singh, S.; Balla, M.; Villa Celi, C.S.;
et al. Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand? Biomedicines 2025, 13, 189.
https://doi.org/10.3390/biomedicines13010189
AMA Style
Vojjala N, Peshin S, Kattamuri LPV, Iqbal R, Dharia A, Jayakumar J, Iftekhar R, Singh S, Balla M, Villa Celi CS,
et al. Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand? Biomedicines. 2025; 13(1):189.
https://doi.org/10.3390/biomedicines13010189
Chicago/Turabian Style
Vojjala, Nikhil, Supriya Peshin, Lakshmi Prasanna Vaishnavi Kattamuri, Rabia Iqbal, Adit Dharia, Jayalekshmi Jayakumar, Rafi Iftekhar, Shagun Singh, Mamtha Balla, Claudia S. Villa Celi,
and et al. 2025. "Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?" Biomedicines 13, no. 1: 189.
https://doi.org/10.3390/biomedicines13010189
APA Style
Vojjala, N., Peshin, S., Kattamuri, L. P. V., Iqbal, R., Dharia, A., Jayakumar, J., Iftekhar, R., Singh, S., Balla, M., Villa Celi, C. S., Ramachandran, R., Prabhu, R., Yadav, S. K., Krishnamoorthy, G., Singh, V., & Seegobin, K.
(2025). Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand? Biomedicines, 13(1), 189.
https://doi.org/10.3390/biomedicines13010189
